Drugs & supplements recalls
Prescription medicines, over-the-counter products and compounded drugs withdrawn from distribution.
-
Class II · 12 months ago
Teva Pharmaceuticals USA, Inc Prazosin Hydrochloride, Capsules, USP, 2 mg recall: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable…
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone / Triamcinolone Acetonide 25MG/5MCG recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter
-
Class II · 12 months ago
ProRx LLC Semaglutide Injection, 6mg/2.4mL , 2.4mL Multidose Vial recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 12 months ago
ProRx LLC Semaglutide Injection, 10 mg/4 mL , 4mL Multidose Vial recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 12 months ago
Bristol-Myers Squibb Company Opdualag injection, 240 mg and 80 mg/20 mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility.
-
Class II · 12 months ago
Aspiro Pharma Limited Ketorolac Tromethamine Injection, USP, 60 mg/2 mL recall: Presence of Particulate Matter: Particulate matter identified as glass
Presence of Particulate Matter: Particulate matter identified as glass
-
Class II · 12 months ago
Church & Dwight Co., Inc. Zicam" Medicated Fruit Drops Elderberry Flavor recall: Labeling: Label Mix-up: The product in the bottle contains elderberry
Labeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient.
-
Class III · 12 months ago
JB Chemicals and Pharmaceuticals Ltd Cetirizine Hydrochloride Tablets USP 10 mg recall: Tablet/Capsules Imprinted with Wrong ID
Tablet/Capsules Imprinted with Wrong ID
-
Class II · 12 months ago
The Harvard Drug Group LLC Gabapentin Capsules, USP, 100 mg, 100 Capsules recall: Failed Impurities/Degradation Specifications: an out of specification result
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
-
Class II · 12 months ago
Medline, Alcohol Prep Pads , 100 eaches per box recall: Subpotent Drug
Subpotent Drug
-
Class II · 12 months ago
USV Private Limited Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 % recall: Failed Impurities/Degradation Specifications: The result for 'Any individual
Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
-
Class II · 12 months ago
ibspot Taoscare Motion Sickness Patches 36-count box recall: Marketed Without an Approved NDA/ANDA
Marketed Without an Approved NDA/ANDA
-
Class III · 12 months ago
JB Chemicals and Pharmaceuticals Ltd Cetirizine Hydrochloride Tablets USP 10 mg recall: Tablet/Capsules Imprinted with Wrong ID
Tablet/Capsules Imprinted with Wrong ID
-
Class II · 12 months ago
The Harvard Drug Group LLC Gabapentin Capsules, USP, 100 mg, 10 Capsules recall: Failed Impurities/Degradation Specifications: an out of specification result
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
-
Class II · 12 months ago
Lannett Company Inc. Niacin Extended-release Tablets, USP, 1,000 mg recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 12 months ago
Graviti Pharmaceuticals Private Limited Bupropion Hydrochloride Extended-Release recall: Failed Tablet/Capsule Specifications
Failed Tablet/Capsule Specifications
-
Class II · 1+ years ago
SV Labs Prescott Corporation Aloe Up Sport Performance Sunscreen Lotion SPF 30 recall: cGMP deviations: the firm released and distributed product which failed total
cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.
-
Class III · 1+ years ago
Endo USA, Inc. Everolimus tablets 5mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class II · 1+ years ago
Glenmark Pharmaceuticals Inc., USA Viorele, Desogestrel and Ethinyl Estradiol, USP recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class III · 1+ years ago
STAQ Pharma, Inc. FentaNYL Citrate PF, 500mcg/50 mL in Nacl, Injection for IV use recall: Labeling: Incorrect or Missing Lot and/or Exp Date
Labeling: Incorrect or Missing Lot and/or Exp Date
-
Class III · 1+ years ago
STAQ Pharma, Inc. Hydromorphone HCL PF, 10mg/50 mL in Nacl, Injection for IV use recall: Labeling: Incorrect or Missing Lot and/or Exp Date
Labeling: Incorrect or Missing Lot and/or Exp Date
-
Class II · 1+ years ago
Ascend Laboratories, LLC Atorvastatin Calcium Tablets USP, 40 mg recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 1+ years ago
Ascend Laboratories, LLC Atorvastatin Calcium Tablets USP, 10 mg recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class I · 1+ years ago
IntegraDose Compounding Services LLC Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride recall: Subpotent Drug: Testing revealed there was no oxytocin in the IV bag
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.